PLASMAFLO OP-05W (A)
FDA premarket approval P820033/S005 · decided 2010-03-16
Approval details
- PMA number
- P820033
- Supplement
- S005
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- PLASMAFLO OP-05W (A)
- Generic name
- Separator for therapeutic purposes, membrane automated blood cell/plasma
- Applicant
- Asahi Kasei Medical Co., Ltd.
- Date received
- 2009-08-18
- Decision date
- 2010-03-16
- Days to decision
- 210 days
- Decision code
- APPR
- Product code
- MDP
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Tokyo
- Statement
- APPROVAL FOR THE PLASMAFLO OP-05W(A). THE DEVICE, IS INTENDED AS A REPLACEMENT FOR THE PLASMAFLO AP-05H AND THE PLASMAFLO AP-05H(L). THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME PLASMAFLO OP-05W(A) AND IS INDICATED FOR USE IN THERAPEUTIC PROCEDURES REQUIRING SEPARATION OF PLASMA FROM WHOLE BLOOD.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Asahi ViE-U Series Dialyzer (K162248) | Asahi Kasei Medical Co., Ltd. | 2017-05-03 |
| Asahi REXEED-S Series Dialyzer (K153344) | Asahi Kasei Medical Co., Ltd. | 2015-12-17 |
| ASAHI REXEED-SX/LX SERIES DIALYZER (K121409) | Asahi Kasei Medical Co., Ltd. | 2013-02-06 |
| ASAHI REXEED-SX/LX DIALYZERS, MODELS: 13SX, 15SX, 18SX, 21SX, 25SX, 13LX, 15LX, 18LX, 21LX (K082515) | Asahi Kasei Medical Co., Ltd. | 2008-10-03 |
| REXEED SERIES DIALYZERS (K051187) | Asahi Kasei Medical Co., Ltd. | 2005-06-08 |